BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2005
View Archived Issues
Cenix and Instituto de Medicina Molecular work together in malaria
Read More
Pivotal phase III study begins for Technosphere Insulin
Read More
Enrollment nears completion in ARISE study of AGI-1067
Read More
Sumitomo licenses amrubicin hydrochloride to Conforma Therapeutics
Read More
First phase III study begins for Evizon in wet AMD
Read More
Peplin progresses PEP-005 Topical for actinic keratosis
Read More
Altana and Pfizer terminate Daxas collaboration
Read More
Paradigm signs agreement with Ortho-McNeil in pain and urinary incontinence
Read More
Agensys submits IND for phase I study of AGS-PSCA
Read More
Johnson & Johnson completes acquisition of Peninsula Pharmaceuticals
Read More
New approval for Topamax
Read More
Genzyme acquisition of Bone Care International approved by shareholders
Read More
Novel analgesics reported in patent literature
Read More
Procyon reflects on FY2004
Read More
Recent patents cover novel antiinfective agents
Read More
Valera seeks Danish approval for Vantas
Read More
SR Pharma to acquire Atugen
Read More
Factor Xa inhibitors, PAI-1 inhibitors in early development
Read More
ZK-187638 is neuroprotective after permanent focal cerebral ischemia in mice
Read More
SUN-N5147 mediates potent antiischemic effects in rats
Read More
Sant-7 potentiates the effect of dexamethasone against multiple myeloma
Read More
Fujisawa scientists discover selective and orally active IP receptor agonist
Read More
Kos inhaled insulin shows promise as adjunct therapy for type 2 diabetes
Read More
Preclinical evidence confirms the antidiabetic effects of CKD-501
Read More
SSR-180575 demonstrates antiischemic effects in cardiac ischemia model
Read More